Applied Dna Sciences Inc (NASDAQ:APDN) price on Wednesday, December 04, fall -5.71% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.18.
A look at the stock’s price movement, the close in the last trading session was $0.20, moving within a range at $0.1704 and $0.1995. The beta value (5-Year monthly) was 0.452. Turning to its 52-week performance, $22.80 and $0.14 were the 52-week high and 52-week low respectively. Overall, APDN moved 0.11% over the past month.
Applied Dna Sciences Inc’s market cap currently stands at around $9.41 million, with investors looking forward to this quarter’s earnings report slated for in January.
Analysts have a consensus estimate of 899k for the company’s revenue for the quarter, with a low and high estimate of 800k and 998k respectively. The average forecast suggests up to a 15.29% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 3.52M, representing a -73.69% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that APDN is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend APDN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
APDN’s current price about 8.08% and -38.30% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 40.75, while 7-day volatility ratio is 15.36% and 9.80% in the 30-day chart. Further, Applied Dna Sciences Inc (APDN) has a beta value of 0.44, and an average true range (ATR) of 0.03. Analysts have given the company’s stock an average 52-week price target of $1.5, forecast between a low of $1.5 and high of $1.5. Looking at the price targets, the low is -733.33% off current price level while to achieve the yearly target high, price needs to move -733.33%. Nonetheless, investors will most likely welcome a -733.33% jump to $1.5 which is the analysts’ median price.
If we refocus on Applied Dna Sciences Inc (NASDAQ:APDN), historical trading data shows that trading volumes averaged 5.4 over the past 10 days and 4.35 million over the past 3 months. The company’s latest data on shares outstanding shows there are 50.90 million shares.
The 0.14% of Applied Dna Sciences Inc’s shares are in the hands of company insiders while institutional holders own 2.12% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.48 million on 2024-11-15, giving us a short ratio of 0.11. The data shows that as of 2024-11-15 short interest in Applied Dna Sciences Inc (APDN) stood at 94.0 of shares outstanding, with shares short falling to 0.85 million registered in 2024-10-15. Current price change has pushed the stock -98.50% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the APDN stock continues to rise going into the next quarter.
